Single-Photon Emission Computed Tomography Market Insights:

Single-photon emission computed tomography (SPECT) Market is a type of medical imaging test that uses a special camera and a radioactive tracer to create detailed pictures of the body's organs and tissues. It is often used to evaluate blood flow and function in the brain, heart, and other organs.

In a recent research report by Market Research Community, the single-photon emission computed tomography market is expected to surpass USD 4.54 Billion by the year 2030, from USD 2.51 Billion in 2021.

Neurology is one of the medical specialties that is expected to drive the growth of the SPECT imaging market in the coming years. This is due, in part, to the fact that SPECT scans can be very useful for evaluating and managing neurological conditions, such as dementia, tumors, stroke, and others.

Get Sample Report Here:

The study is consolidated into major segments and further into sub-segments, such as by type (standalone SPECT systems, hybrid SPECT systems), by application (cardiology, oncology, and neurology), by end-use (diagnostic imaging centers, hospitals), to forecast the market size by value

By Type     

  • Hybrid SPECT Systems
  • Standalone SPECT Systems

By Application

  • Oncology,
  • Cardiology,
  • Neurology

By End-Use

  • Hospitals
  • Diagnostic Imaging Centers

In the projected time, Asia-Pacific is estimated to have the second highest market share due to the increased expansion of the single-photon emission computed tomography market. Factors such as rising healthcare infrastructure development spending and increased cases of chronic diseases among geriatric pollution, which is highly susceptible to the need for surgical intervention for treatment, are major contributors to the Asia Pacific region's single-photon emission computed tomography market growth.

Lastly, the Single-photon emission computed tomography (SPECT) Market Trends report includes a regional analysis and country analysis with the latest trends, along with the major key players including Bruker Corporation, Digirad Corporation, Spectrum Dynamics Medical, DDD-Diagnostic A/S, MiE America Inc., CardiArc, GE Healthcare, Siemens Healthcare, Mediso Ltd., Koninklijke Philips N.V.


Market Research Community